Current concepts of myeloproliferative diseases
Steruská, M.; Hrubisko, M.
Vnitrni Lekarstvi 23(7): 706-711
1977
ISSN/ISBN: 0042-773X PMID: 898706 Document Number: 119447
Document emailed within 1 workday
Related Documents
Homma, M. 1978: Current concepts of autoimmune diseases Nihon Rinsho. Japanese Journal of Clinical Medicine Suppl: 1176-1177Boitard, C. 1987: Physiopathology of autoimmune endocrine diseases: current concepts Annales de Medecine Interne 138(8): 645-656
Bastin, R.; Charmot, G.; Vildé, J.L. 1972: Infectious amd parasitic diseases. Survey of current concepts in 1972 La Revue du Praticien 22(27): 3625-3658
Neurath, M.F. 2000: Immunotherapy of inflammatory bowel diseases: current concepts and future perspectives Archivum Immunologiae et Therapiae Experimentalis 48(2): 81-84
Dmitriev, A.A. 1983: Current concepts of hemoperfusion through activated charcoal in the treatment of internal diseases Terapevticheskii Arkhiv 55(6): 140-148
Burton, B.T. 1974: Current concepts of nutrition and diet in diseases of the kidney. I. General principles of dietary management Journal of the American Dietetic Association 65(6): 623-626
Guptan, R.C.; Thakur, V.; Sarin, S.K. 1996: Iron and liver: current concepts in the pathogenesis and management of chronic liver diseases Journal of the Association of Physicians of India 44(3): 198-202
Aulbert, E.; Fromm, H. 1990: Ferritin in myeloproliferative diseases Medizinische Klinik 85(3): 125-131
Jaillon, P. 1986: Current therapeutic concepts in the treatment of myocardial ischemia. Current and future drugs Annales de Cardiologie et d'Angeiologie 35(7 Pt 2): 453-458
Van Bellen, B.; Yao, J.S. 1977: Deep venous thrombosis. Current concepts of ethiopathogenesis and current diagnostic methods Amb: Revista da Associacao Medica Brasileira 23(6): 220-222
Zankovich, R. 1989: Chronic myeloproliferative diseases. 3: Osteomyelofibrosis Fortschritte der Medizin 107(34): 736-740
Zankovich, R. 1989: Chronic myeloproliferative diseases. 3: Osteomyelofibrosis Fortschritte der Medizin 107(34): 736-740
Adam, Z. 1993: Interferon-alfa in the treatment of myeloproliferative diseases Vnitrni Lekarstvi 39(12): 1210-1218
Kissová, J. 2019: Interferon-alpha in the treatment of myeloproliferative diseases Vnitrni Lekarstvi 65(11): 699-703
Fernández Rodríguez, M.N. 1971: Chronic myeloproliferative diseases. Clinical and cytogenetic study Sangre 16(2): 159-184
Zankovich, R. 1989: Chronic myeloproliferative diseases. 2: Polycythemia vera rubra Fortschritte der Medizin 107(33): 717-719
Rukavitsyn, O.A.; Pop, V.P.; Seriakov, A.P. 2004: Choice of therapy and overall survival in patients with chronic myeloproliferative diseases Voprosy Onkologii 50(4): 435-439
Benöhr, H.C.; Kraft, R.; Waller, H.D. 1976: Reduced glutathione and enzyme activities in erythrocytes of various again myeloproliferative diseases Verhandlungen der Deutschen Gesellschaft für Innere Medizin 82 Pt 2: 1592-1595
Bock, O. 2007: Molecular diagnosis of chronic myeloproliferative diseases and myelodysplastic syndromes Verhandlungen der Deutschen Gesellschaft für Pathologie 91: 140-153
Linkesch, W.; Gisslinger, H.; Ludwig, H.; Flener, R.; Sinzinger, H. 1985: Therapy with interferon (recombinant IFN-alpha-2C) in myeloproliferative diseases with severe thrombocytoses Acta Medica Austriaca 12(5): 123-127